NG Biotech is a French biotech company at the forefront of developing and manufacturing cutting-edge in vitro diagnostic tools for Therapy Monitoring at the Point of Care (Onsite). They offer a wide range of products and services tailored to various medical needs. With a strong focus on antimicrobial resistance detection, NG Biotech provides innovative solutions for identifying and monitoring human-bacterial infections, carbapenemase resistance, ESBL resistance, and colistin resistance.

They also offer blood culture sample preparation and tests for women's health and over-the-counter and professional use. In response to the global COVID-19 pandemic, NG Biotech has developed technology and customizable applications for medical diagnostics, companion diagnostics, and animal health diagnostics. They also offer clinical trials services, custom developments, and manufacturing capabilities.

By combining their expertise with advanced technology, NG Biotech plays a crucial role in the fight against antimicrobial resistance and strives to improve patient outcomes through rapid, mobile, and connected diagnostics